You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

essential thrombocytosis

Showing 1 - 25 of 4,703
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

The Role of Circ0014614 in the Formation and Development of ET

Recruiting
  • Primary Thrombocytosis
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jun 18, 2023

    Real World Evidence of Fedratinib Effectiveness in MF

    Not yet recruiting
    • Primary Myelofibrosis
    • +2 more
    • (no location specified)
    May 22, 2023

    Assess the Safety of Fedratinib in Korean Myelofibrosis

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

    Not yet recruiting
    • Essential Thrombocythemia
    • (no location specified)
    Oct 6, 2023

    Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

    Not yet recruiting
    • Myeloproliferative Disorders
    • +3 more
    • (no location specified)
    Nov 21, 2023

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

      Recruiting
      • Essential Thrombocytopenia
      • Recombinant Interferon Alpha
      • Pegylated interferon alfa-2b
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jul 18, 2022

      Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

      Not yet recruiting
      • Essential Thrombocythemia
      • Ropeginterferon alfa-2b-njft (P1101)
      • (no location specified)
      Jul 28, 2022

      Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +4 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Jan 6, 2023

      Polycythemia Vera, Essential Thrombocythemia, and

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Next-generation sequencing
      • (no location specified)
      Jun 27, 2022

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

      Recruiting
      • Primary Myelofibrosis
      • +4 more
      • New York, New York
        Ruttenberg Treatment Center
      Jul 18, 2022

      Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

      Recruiting
      • Myeloproliferative Neoplasm
      • +3 more
      • CALR allele burden quantification
      • Angers, France
        CHU Angers
      Nov 2, 2022

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

      Terminated
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Larkspur, California
      • +2 more
      Nov 14, 2022

      Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

      Not yet recruiting
      • Myelofibrosis
      • +2 more
      • Peptide-based vaccine
      • Poly ICLC
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jun 7, 2022

      Arterial Function and Atherosclerosis in Essential

      Completed
      Has Results
      • Atherosclerosis
      • imaging
      • (no location specified)
      Oct 6, 2021

      Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

      Recruiting
      • Thrombocythemia, Essential
      • San Antonio, Texas
        Mays Cancer Center
      Dec 14, 2021

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

      Recruiting
      • Myelofibrosis; Anemia
      • +5 more
      • Jacksonville, Florida
      • +6 more
      Jan 3, 2023

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

      Terminated
      • Essential Thrombocythemia
      • +2 more
      • Arsenic Trioxide
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 20, 2022

      Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

      Recruiting
      • Primary Myelofibrosis
      • +9 more
      • Observational
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 11, 2022

      Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

      Recruiting
      • Acute Myeloid Leukemia
      • +8 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 18, 2022

      Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

      Completed
      • Myelofibrosis
      • +3 more
      • Ann Arbor, Michigan
      • +4 more
      Mar 28, 2022